+772.1%
MRNA vs OMC
+23.2%
+748.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | OMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.7% | -2.0% |
| 7D | -12.7% | -3.2% | -9.5% | -11.4% |
| 30D | -20.7% | +5.8% | -26.5% | -22.8% |
| 3M | +46.3% | -1.2% | +47.4% | +46.9% |
| 6M | +305.2% | +21.0% | +284.2% | +275.8% |
| YTD | +561.2% | +8.8% | +552.5% | +537.6% |
| 1Y | +772.1% | +24.1% | +748.0% | +700.7% |
| All | +772.1% | +23.2% | +748.9% | +700.7% |
Cumulative growth
Daily Returns
Daily percentage return beside OMC.
Daily Out/Under-Performance
Portfolio return minus OMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded OMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling